Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 247

1.

Unique MicroRNA and mRNA Interactions in EGFR-Mutated Lung Adenocarcinoma.

Subat S, Inamura K, Ninomiya H, Nagano H, Okumura S, Ishikawa Y.

J Clin Med. 2018 Nov 6;7(11). pii: E419. doi: 10.3390/jcm7110419.

2.

Impact of CDX2 expression status on the survival of patients after curative resection for colorectal cancer liver metastasis.

Shigematsu Y, Inamura K, Yamamoto N, Mise Y, Saiura A, Ishikawa Y, Takahashi S, Kanda H.

BMC Cancer. 2018 Oct 16;18(1):980. doi: 10.1186/s12885-018-4902-8.

3.

Fusobacterium nucleatum in Colorectal Cancer Relates to Immune Response Differentially by Tumor Microsatellite Instability Status.

Hamada T, Zhang X, Mima K, Bullman S, Sukawa Y, Nowak JA, Kosumi K, Masugi Y, Twombly TS, Cao Y, Song M, Liu L, da Silva A, Shi Y, Gu M, Li W, Koh H, Nosho K, Inamura K, Keum N, Wu K, Meyerhardt JA, Kostic AD, Huttenhower C, Garrett WS, Meyerson M, Giovannucci EL, Chan AT, Fuchs CS, Nishihara R, Giannakis M, Ogino S.

Cancer Immunol Res. 2018 Nov;6(11):1327-1336. doi: 10.1158/2326-6066.CIR-18-0174. Epub 2018 Sep 18.

PMID:
30228205
4.

Vitamin D status after colorectal cancer diagnosis and patient survival according to immune response to tumour.

Hamada T, Liu L, Nowak JA, Mima K, Cao Y, Ng K, Twombly TS, Song M, Jung S, Dou R, Masugi Y, Kosumi K, Shi Y, da Silva A, Gu M, Li W, Keum N, Wu K, Nosho K, Inamura K, Meyerhardt JA, Nevo D, Wang M, Giannakis M, Chan AT, Giovannucci EL, Fuchs CS, Nishihara R, Zhang X, Ogino S.

Eur J Cancer. 2018 Nov;103:98-107. doi: 10.1016/j.ejca.2018.07.130. Epub 2018 Sep 13.

PMID:
30219720
5.

CSF1R-Expressing Tumor-Associated Macrophages, Smoking and Survival in Lung Adenocarcinoma: Analyses Using Quantitative Phosphor-Integrated Dot Staining.

Inamura K, Shigematsu Y, Ninomiya H, Nakashima Y, Kobayashi M, Saito H, Takahashi K, Futaya E, Okumura S, Ishikawa Y, Kanda H.

Cancers (Basel). 2018 Jul 31;10(8). pii: E252. doi: 10.3390/cancers10080252.

6.

Tumor B7-H3 (CD276) Expression and Survival in Pancreatic Cancer.

Inamura K, Takazawa Y, Inoue Y, Yokouchi Y, Kobayashi M, Saiura A, Shibutani T, Ishikawa Y.

J Clin Med. 2018 Jul 10;7(7). pii: E172. doi: 10.3390/jcm7070172.

7.

TIME (Tumor Immunity in the MicroEnvironment) classification based on tumor CD274 (PD-L1) expression status and tumor-infiltrating lymphocytes in colorectal carcinomas.

Hamada T, Soong TR, Masugi Y, Kosumi K, Nowak JA, da Silva A, Mu XJ, Twombly TS, Koh H, Yang J, Song M, Liu L, Gu M, Shi Y, Nosho K, Morikawa T, Inamura K, Shukla SA, Wu CJ, Garraway LA, Zhang X, Wu K, Meyerhardt JA, Chan AT, Glickman JN, Rodig SJ, Freeman GJ, Fuchs CS, Nishihara R, Giannakis M, Ogino S.

Oncoimmunology. 2018 Mar 19;7(7):e1442999. doi: 10.1080/2162402X.2018.1442999. eCollection 2018.

PMID:
29900052
8.
9.

CDX2 expression is concordant between primary colorectal cancer lesions and corresponding liver metastases independent of chemotherapy: a single-center retrospective study in Japan.

Shigematsu Y, Inamura K, Mise Y, Saiura A, Rehnberg E, Yamamoto N, Ishikawa Y, Takahashi S, Kanda H.

Oncotarget. 2018 Mar 30;9(24):17056-17065. doi: 10.18632/oncotarget.24842. eCollection 2018 Mar 30.

10.

Bladder Cancer: New Insights into Its Molecular Pathology.

Inamura K.

Cancers (Basel). 2018 Apr 1;10(4). pii: E100. doi: 10.3390/cancers10040100. Review.

11.

Prostatic cancers: understanding their molecular pathology and the 2016 WHO classification.

Inamura K.

Oncotarget. 2018 Feb 16;9(18):14723-14737. doi: 10.18632/oncotarget.24515. eCollection 2018 Mar 6. Review.

12.

Update on Immunohistochemistry for the Diagnosis of Lung Cancer.

Inamura K.

Cancers (Basel). 2018 Mar 14;10(3). pii: E72. doi: 10.3390/cancers10030072. Review.

13.

Genetic Mechanisms of Immune Evasion in Colorectal Cancer.

Grasso CS, Giannakis M, Wells DK, Hamada T, Mu XJ, Quist M, Nowak JA, Nishihara R, Qian ZR, Inamura K, Morikawa T, Nosho K, Abril-Rodriguez G, Connolly C, Escuin-Ordinas H, Geybels MS, Grady WM, Hsu L, Hu-Lieskovan S, Huyghe JR, Kim YJ, Krystofinski P, Leiserson MDM, Montoya DJ, Nadel BB, Pellegrini M, Pritchard CC, Puig-Saus C, Quist EH, Raphael BJ, Salipante SJ, Shin DS, Shinbrot E, Shirts B, Shukla S, Stanford JL, Sun W, Tsoi J, Upfill-Brown A, Wheeler DA, Wu CJ, Yu M, Zaidi SH, Zaretsky JM, Gabriel SB, Lander ES, Garraway LA, Hudson TJ, Fuchs CS, Ribas A, Ogino S, Peters U.

Cancer Discov. 2018 Jun;8(6):730-749. doi: 10.1158/2159-8290.CD-17-1327. Epub 2018 Mar 6.

PMID:
29510987
14.

Anosognosia in mild Alzheimer's disease is correlated with not only neural dysfunction but also compensation.

Tagai K, Shinagawa S, Kada H, Inamura K, Nagata T, Nakayama K.

Psychogeriatrics. 2018 Mar;18(2):81-88. doi: 10.1111/psyg.12287. Epub 2018 Feb 6.

PMID:
29409154
15.

Colorectal Cancers: An Update on Their Molecular Pathology.

Inamura K.

Cancers (Basel). 2018 Jan 20;10(1). pii: E26. doi: 10.3390/cancers10010026. Review.

16.

Diagnostic Ability with Abbreviated Biparametric and Full Multiparametric Prostate MR Imaging: Is the Use of PI-RADS Version 2 Appropriate for Comparison?

Kaji Y, Inamura K.

Radiology. 2018 Feb;286(2):726-727. doi: 10.1148/radiol.2017172265. No abstract available.

PMID:
29356639
17.

Osteosarcoma arising in fibrous dysplasia, confirmed by mutational analysis of GNAS gene.

Sugiura Y, Kanda H, Motoi N, Nomura K, Inamura K, Okada E, Matsumoto H, Shimoji T, Matsumoto S, Nakayama J, Takazawa Y, Ishikawa Y, Machinami R.

Pathol Res Pract. 2018 Feb;214(2):318-324. doi: 10.1016/j.prp.2017.10.018. Epub 2017 Nov 12.

PMID:
29268950
18.

Prognosis of type 1 autoimmune pancreatitis after corticosteroid therapy-induced remission in terms of relapse and diabetes mellitus.

Miyazawa M, Takatori H, Shimakami T, Kawaguchi K, Kitamura K, Arai K, Matsuda K, Sanada T, Urabe T, Inamura K, Kagaya T, Mizuno H, Fuchizaki U, Yamashita T, Sakai Y, Yamashita T, Mizukoshi E, Honda M, Kaneko S.

PLoS One. 2017 Nov 22;12(11):e0188549. doi: 10.1371/journal.pone.0188549. eCollection 2017.

19.

[A case of gastric follicular lymphoma resected and diagnosed with laparoscopy and endoscopy cooperative surgery].

Seike T, Inamura K, Okuno N, Asaumi Y, Takata Y, Okamura T, Matano S, Terahata S, Sakatoku K, Kawai H.

Nihon Shokakibyo Gakkai Zasshi. 2017;114(11):1996-2004. doi: 10.11405/nisshoshi.114.1996. Review. Japanese.

PMID:
29109348
20.

Prognostic Effect of Lymphovascular Invasion on TNM Staging in Stage I Non-Small-cell Lung Cancer.

Noma D, Inamura K, Matsuura Y, Hirata Y, Nakajima T, Yamazaki H, Hirai Y, Ichinose J, Nakao M, Ninomiya H, Mun M, Nakagawa K, Masuda M, Ishikawa Y, Okumura S.

Clin Lung Cancer. 2018 Jan;19(1):e109-e122. doi: 10.1016/j.cllc.2017.06.001. Epub 2017 Jun 20.

PMID:
29066222
21.

Renal Cell Tumors: Understanding Their Molecular Pathological Epidemiology and the 2016 WHO Classification.

Inamura K.

Int J Mol Sci. 2017 Oct 20;18(10). pii: E2195. doi: 10.3390/ijms18102195. Review.

22.

Tumor PDCD1LG2 (PD-L2) Expression and the Lymphocytic Reaction to Colorectal Cancer.

Masugi Y, Nishihara R, Hamada T, Song M, da Silva A, Kosumi K, Gu M, Shi Y, Li W, Liu L, Nevo D, Inamura K, Cao Y, Liao X, Nosho K, Chan AT, Giannakis M, Bass AJ, Hodi FS, Freeman GJ, Rodig SJ, Fuchs CS, Qian ZR, Nowak JA, Ogino S.

Cancer Immunol Res. 2017 Nov;5(11):1046-1055. doi: 10.1158/2326-6066.CIR-17-0122. Epub 2017 Oct 16.

23.

Pilot study on novel blood containers with alternative plasticizers for red cell concentrate storage.

Morishita Y, Nomura Y, Fukui C, Kawakami T, Ikeda T, Mukai T, Yuba T, Inamura KI, Yamaoka H, Miyazaki KI, Okazaki H, Haishima Y.

PLoS One. 2017 Sep 28;12(9):e0185737. doi: 10.1371/journal.pone.0185737. eCollection 2017.

24.

Relationship of tumor PD-L1 (CD274) expression with lower mortality in lung high-grade neuroendocrine tumor.

Inamura K, Yokouchi Y, Kobayashi M, Ninomiya H, Sakakibara R, Nishio M, Okumura S, Ishikawa Y.

Cancer Med. 2017 Oct;6(10):2347-2356. doi: 10.1002/cam4.1172. Epub 2017 Sep 18.

25.

Lung Cancer: Understanding Its Molecular Pathology and the 2015 WHO Classification.

Inamura K.

Front Oncol. 2017 Aug 28;7:193. doi: 10.3389/fonc.2017.00193. eCollection 2017. Review.

26.

Skene's gland adenocarcinoma with intestinal differentiation: A case report and literature review.

Muto M, Inamura K, Ozawa N, Endo T, Masuda H, Yonese J, Ishikawa Y.

Pathol Int. 2017 Nov;67(11):575-579. doi: 10.1111/pin.12571. Epub 2017 Sep 5. Review.

PMID:
28872768
27.

Association Between Inflammatory Diet Pattern and Risk of Colorectal Carcinoma Subtypes Classified by Immune Responses to Tumor.

Liu L, Nishihara R, Qian ZR, Tabung FK, Nevo D, Zhang X, Song M, Cao Y, Mima K, Masugi Y, Shi Y, da Silva A, Twombly T, Gu M, Li W, Hamada T, Kosumi K, Inamura K, Nowak JA, Drew DA, Lochhead P, Nosho K, Wu K, Wang M, Garrett WS, Chan AT, Fuchs CS, Giovannucci EL, Ogino S.

Gastroenterology. 2017 Dec;153(6):1517-1530.e14. doi: 10.1053/j.gastro.2017.08.045. Epub 2017 Sep 1.

28.

Translocation Renal Cell Carcinoma: An Update on Clinicopathological and Molecular Features.

Inamura K.

Cancers (Basel). 2017 Aug 29;9(9). pii: E111. doi: 10.3390/cancers9090111. Review.

29.

[Diagnostic Impact of 3D-CT with Retrograde Pyelography for Ureteropelvic Junction Obstruction : A Case Report].

Takei K, Abe H, Nishihara D, Mizuno T, Tokura Y, Suzuki I, Sakamoto K, Yuki H, Kambara T, Betsunou H, Yashi M, Fukabori Y, Kamai T, Inamura K, Shioyama Y, Kaji Y.

Hinyokika Kiyo. 2017 Jul;63(7):267-270. doi: 10.14989/ActaUrolJap_63_7_267. Japanese.

30.

Evaluation of an e-learning system for diagnosis of gastric lesions using magnifying narrow-band imaging: a multicenter randomized controlled study.

Nakanishi H, Doyama H, Ishikawa H, Uedo N, Gotoda T, Kato M, Nagao S, Nagami Y, Aoyagi H, Imagawa A, Kodaira J, Mitsui S, Kobayashi N, Muto M, Takatori H, Abe T, Tsujii M, Watari J, Ishiyama S, Oda I, Ono H, Kaneko K, Yokoi C, Ueo T, Uchita K, Matsumoto K, Kanesaka T, Morita Y, Katsuki S, Nishikawa J, Inamura K, Kinjo T, Yamamoto K, Yoshimura D, Araki H, Kashida H, Hosokawa A, Mori H, Yamashita H, Motohashi O, Kobayashi K, Hirayama M, Kobayashi H, Endo M, Yamano H, Murakami K, Koike T, Hirasawa K, Miyaoka Y, Hamamoto H, Hikichi T, Hanabata N, Shimoda R, Hori S, Sato T, Kodashima S, Okada H, Mannami T, Yamamoto S, Niwa Y, Yashima K, Tanabe S, Satoh H, Sasaki F, Yamazato T, Ikeda Y, Nishisaki H, Nakagawa M, Matsuda A, Tamura F, Nishiyama H, Arita K, Kawasaki K, Hoppo K, Oka M, Ishihara S, Mukasa M, Minamino H, Yao K.

Endoscopy. 2017 Oct;49(10):957-967. doi: 10.1055/s-0043-111888. Epub 2017 Jun 21.

PMID:
28637065
31.

Neurochemical and neuropharmacological characterization of ASP2905, a novel potent selective inhibitor of the potassium channel KCNH3.

Takahashi S, Inamura K, Yarimizu J, Yamazaki M, Murai N, Ni K.

Eur J Pharmacol. 2017 Sep 5;810:26-35. doi: 10.1016/j.ejphar.2017.05.045. Epub 2017 May 25.

PMID:
28552344
32.

A novel fusion of HNRNPA1-ALK in inflammatory myofibroblastic tumor of urinary bladder.

Inamura K, Kobayashi M, Nagano H, Sugiura Y, Ogawa M, Masuda H, Yonese J, Ishikawa Y.

Hum Pathol. 2017 Nov;69:96-100. doi: 10.1016/j.humpath.2017.04.022. Epub 2017 May 10.

PMID:
28504207
33.

Alternative plasticizer, 4-cyclohexene-1,2-dicarboxylic acid dinonyl ester, for blood containers with protective effects on red blood cells and improved cold resistance.

Morishita Y, Nomura Y, Fukui C, Fujisawa A, Watanabe K, Fujimaki H, Kumada H, Inoue K, Morikawa T, Takahashi M, Kawakami T, Sakoda H, Mukai T, Yuba T, Inamura KI, Tanoue A, Miyazaki KI, Chung UI, Ogawa K, Yoshida M, Haishima Y.

J Biomed Mater Res B Appl Biomater. 2018 Apr;106(3):1052-1063. doi: 10.1002/jbm.b.33916. Epub 2017 May 13.

PMID:
28500731
34.

Major Tumor Suppressor and Oncogenic Non-Coding RNAs: Clinical Relevance in Lung Cancer.

Inamura K.

Cells. 2017 May 9;6(2). pii: E12. doi: 10.3390/cells6020012. Review.

35.

Diagnostic and Therapeutic Potential of MicroRNAs in Lung Cancer.

Inamura K.

Cancers (Basel). 2017 May 9;9(5). pii: E49. doi: 10.3390/cancers9050049. Review.

36.

Association of tumor TROP2 expression with prognosis varies among lung cancer subtypes.

Inamura K, Yokouchi Y, Kobayashi M, Ninomiya H, Sakakibara R, Subat S, Nagano H, Nomura K, Okumura S, Shibutani T, Ishikawa Y.

Oncotarget. 2017 Apr 25;8(17):28725-28735. doi: 10.18632/oncotarget.15647.

37.

Guest editorial for the IJCARS special issue on JAMIT 2015 and 2016.

Shimizu A, Sato Y, Inamura K.

Int J Comput Assist Radiol Surg. 2017 May;12(5):705-706. doi: 10.1007/s11548-017-1581-x. No abstract available.

PMID:
28391582
38.

EBUS-TBNA as a Promising Method for the Evaluation of Tumor PD-L1 Expression in Lung Cancer.

Sakakibara R, Inamura K, Tambo Y, Ninomiya H, Kitazono S, Yanagitani N, Horiike A, Ohyanagi F, Matsuura Y, Nakao M, Mun M, Okumura S, Inase N, Nishio M, Motoi N, Ishikawa Y.

Clin Lung Cancer. 2017 Sep;18(5):527-534.e1. doi: 10.1016/j.cllc.2016.12.002. Epub 2016 Dec 22.

PMID:
28111119
39.

Tumor B7-H3 (CD276) expression and smoking history in relation to lung adenocarcinoma prognosis.

Inamura K, Yokouchi Y, Kobayashi M, Sakakibara R, Ninomiya H, Subat S, Nagano H, Nomura K, Okumura S, Shibutani T, Ishikawa Y.

Lung Cancer. 2017 Jan;103:44-51. doi: 10.1016/j.lungcan.2016.11.013. Epub 2016 Nov 17. Retraction in: Lung Cancer. 2016 Dec 10;243:21-28.

PMID:
28024695
40.

Interobserver agreement in detection of "white globe appearance" and the ability of educational lectures to improve the diagnosis of gastric lesions.

Omura H, Yoshida N, Hayashi T, Miwa K, Takatori H, Tsuji H, Inamura K, Shirota Y, Aoyagi H, Masunaga T, Katayanagi K, Kurumaya H, Kaneko S, Doyama H.

Gastric Cancer. 2017 Jul;20(4):620-628. doi: 10.1007/s10120-016-0676-3. Epub 2016 Dec 3.

PMID:
27915451
41.

Imaging findings of gastric calcifying fibrous tumour.

Miyashita S, Ryu Y, Takata H, Asaumi Y, Sakatoku M, Seike T, Okamura T, Inamura K, Kawai H, Okuno N, Terahata S.

BJR Case Rep. 2016 Nov 2;2(4):20160064. doi: 10.1259/bjrcr.20160064. eCollection 2016.

42.

Genomic Correlates of Immune-Cell Infiltrates in Colorectal Carcinoma.

Giannakis M, Mu XJ, Shukla SA, Qian ZR, Cohen O, Nishihara R, Bahl S, Cao Y, Amin-Mansour A, Yamauchi M, Sukawa Y, Stewart C, Rosenberg M, Mima K, Inamura K, Nosho K, Nowak JA, Lawrence MS, Giovannucci EL, Chan AT, Ng K, Meyerhardt JA, Van Allen EM, Getz G, Gabriel SB, Lander ES, Wu CJ, Fuchs CS, Ogino S, Garraway LA.

Cell Rep. 2016 Oct 18;17(4):1206. doi: 10.1016/j.celrep.2016.10.009. No abstract available.

43.

Association Between Somatostatin Receptor Expression and Clinical Outcomes in Neuroendocrine Tumors.

Qian ZR, Li T, Ter-Minassian M, Yang J, Chan JA, Brais LK, Masugi Y, Thiaglingam A, Brooks N, Nishihara R, Bonnemarie M, Masuda A, Inamura K, Kim SA, Mima K, Sukawa Y, Dou R, Lin X, Christiani DC, Schmidlin F, Fuchs CS, Mahmood U, Ogino S, Kulke MH.

Pancreas. 2016 Nov;45(10):1386-1393.

44.

WITHDRAWN: Tumor B7-H3 (CD276) expression and smoking history in relation to lung adenocarcinoma prognosis.

Inamura K, Yokouchi Y, Kobayashi M, Sakakibara R, Ninomiya H, Subat S, Nagano H, Nomura K, Okumura S, Shibutani T, Ishikawa Y.

Lung Cancer. 2016 Dec 10;243:21-28. doi: 10.1016/j.lungcan.2016.09.016. Epub 2016 Oct 1.

PMID:
27721121
45.

Thymic oncocytic carcinoid with a markedly elevated level of maximum SUV.

Noma D, Inamura K, Mun M, Terauchi T, Matsuura Y, Nakao M, Ninomiya H, Nakagawa K, Masuda M, Okumura S, Ishikawa Y.

Pathol Int. 2016 Oct;66(10):593-595. doi: 10.1111/pin.12449. Epub 2016 Sep 11. No abstract available.

PMID:
27614899
46.

Relationship of tumor PD-L1 expression with EGFR wild-type status and poor prognosis in lung adenocarcinoma.

Inamura K, Yokouchi Y, Sakakibara R, Kobayashi M, Subat S, Ninomiya H, Nagano H, Nomura K, Okumura S, Ishikawa Y.

Jpn J Clin Oncol. 2016 Oct;46(10):935-941. Epub 2016 Aug 10.

PMID:
27511990
47.

Regular Aspirin Use Associates With Lower Risk of Colorectal Cancers With Low Numbers of Tumor-Infiltrating Lymphocytes.

Cao Y, Nishihara R, Qian ZR, Song M, Mima K, Inamura K, Nowak JA, Drew DA, Lochhead P, Nosho K, Morikawa T, Zhang X, Wu K, Wang M, Garrett WS, Giovannucci EL, Fuchs CS, Chan AT, Ogino S.

Gastroenterology. 2016 Nov;151(5):879-892.e4. doi: 10.1053/j.gastro.2016.07.030. Epub 2016 Jul 27.

48.

Tumour CD274 (PD-L1) expression and T cells in colorectal cancer.

Masugi Y, Nishihara R, Yang J, Mima K, da Silva A, Shi Y, Inamura K, Cao Y, Song M, Nowak JA, Liao X, Nosho K, Chan AT, Giannakis M, Bass AJ, Hodi FS, Freeman GJ, Rodig S, Fuchs CS, Qian ZR, Ogino S.

Gut. 2017 Aug;66(8):1463-1473. doi: 10.1136/gutjnl-2016-311421. Epub 2016 May 5.

49.

Detection of rapidly progressing hepatic angiosarcoma on autopsy that would have definitely been diagnosable on percutaneous liver biopsy.

Saito H, Goto T, Inamura K, Iwasaki N, Yamabe S, Tada S, Urata J, Toyozumi Y, Arima N.

Nihon Shokakibyo Gakkai Zasshi. 2016 May;113(5):837-40. doi: 10.11405/nisshoshi.113.837. Japanese. No abstract available.

PMID:
27151481
50.

Genomic Correlates of Immune-Cell Infiltrates in Colorectal Carcinoma.

Giannakis M, Mu XJ, Shukla SA, Qian ZR, Cohen O, Nishihara R, Bahl S, Cao Y, Amin-Mansour A, Yamauchi M, Sukawa Y, Stewart C, Rosenberg M, Mima K, Inamura K, Nosho K, Nowak JA, Lawrence MS, Giovannucci EL, Chan AT, Ng K, Meyerhardt JA, Van Allen EM, Getz G, Gabriel SB, Lander ES, Wu CJ, Fuchs CS, Ogino S, Garraway LA.

Cell Rep. 2016 Apr 26;15(4):857-865. doi: 10.1016/j.celrep.2016.03.075. Epub 2016 Apr 14. Erratum in: Cell Rep. 2016 Oct 18;17 (4):1206.

Supplemental Content

Loading ...
Support Center